Fibrinolysis in Intermediate-Risk PE Between Prevention and Risk – Unidad de ETV Hospital Gregorio Marañón
Unidad de ETV Hospital Gregorio Marañón shared a post on X about a recent article by Eva Cervilla-Muñoz et al., published in Journal of Clinical Medicine:
“The use of systemic fibrinolysis in intermediate-risk PE remains one of the great clinical debates: Prevent hemodynamic deterioration or assume greater hemorrhagic risk?
In our new article, conducted together with CardioHGUGM, we analyze a real-world cohort.”
Title: Systemic Fibrinolysis in Symptomatic Intermediate-Risk Pulmonary Embolism: A Real-World Cohort Study
Authors: Eva Cervilla-Muñoz, Pablo Demelo-Rodríguez, Rubén Alonso-Beato, Miriam Juárez-Fernández, Iago Sousa-Casasnovas, Lucía Ordieres-Ortega, Marina López-Rubio, Luis-Antonio Alvarez-Sala Walther, Francisco Galeano-Valle
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 29, 2026, 14:08Shivam Gupta: Heat Stroke Awareness Program by SGB by BrandSafway Calls for Hydration and Rapid Response
-
Apr 29, 2026, 14:07Manmit Kaur: Advancing Practice and Reaching New Personal Goals in One Week
-
Apr 29, 2026, 14:03Blood Clots Can Happen to Anyone – NBCA
-
Apr 29, 2026, 14:03Tushar Pandey: The Spectrum of Bleeding Disorders
-
Apr 29, 2026, 14:03Yesehak Abraham: Enoxaparin Is The Quiet Hero in Clot Prevention
-
Apr 29, 2026, 14:00Advancing Rapid Prehospital Stroke Diagnosis Through StrokeCap Innovative Technology – ForTra
-
Apr 29, 2026, 13:52Bhaskar Tripathi: Heat Stroke Is a Silent Workplace Hazard We Can’t Ignore
-
Apr 29, 2026, 13:48Flora Peyvandi: Point-of-Care Testing for Rapid Detection of Factor VIII Inhibitors in Haemophilia A
-
Apr 29, 2026, 13:25Ajay Samkaria: Prevention of Alloimmunization in Females of Childbearing Age